Akshay Vaishnaw is President of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 22,774 shares of ALNY, which is worth approximately $5.81 Million. The most recent transaction as insider was on Aug 04, 2023, when has been sold 4,057 shares (Common Stock) at a price of $186.95 per share, resulting in proceeds of $758,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.8K
0% 3M change
27.3% 12M change
Total Value Held $5.81 Million

Akshay Vaishnaw Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 04 2023
SELL
Open market or private sale
$758,456 $186.95 p/Share
4,057 Reduced 15.12%
22,774 Common Stock
Aug 03 2023
BUY
Grant, award, or other acquisition
-
8,941 Added 24.99%
26,831 Common Stock
Apr 27 2023
SELL
Open market or private sale
$466,344 $194.96 p/Share
2,392 Reduced 11.79%
17,890 Common Stock
Apr 26 2023
BUY
Grant, award, or other acquisition
-
5,312 Added 20.75%
20,282 Common Stock
Feb 10 2023
SELL
Open market or private sale
$8,190,492 $215.29 p/Share
38,044 Reduced 71.76%
14,970 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
$1,947,519 $63.0 p/Share
30,913 Added 36.83%
53,014 Common Stock
Dec 05 2022
SELL
Payment of exercise price or tax liability
$299,488 $226.2 p/Share
1,324 Reduced 5.65%
22,101 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$328,712 $64.72 p/Share
5,079 Added 17.82%
23,425 Common Stock
Aug 04 2022
SELL
Payment of exercise price or tax liability
$1,242,778 $205.35 p/Share
6,052 Reduced 24.81%
18,346 Common Stock
Aug 03 2022
BUY
Grant, award, or other acquisition
-
13,183 Added 35.08%
24,398 Common Stock
Dec 23 2021
SELL
Open market or private sale
$547,701 $190.24 p/Share
2,879 Reduced 20.43%
11,215 Common Stock
Dec 22 2021
SELL
Payment of exercise price or tax liability
$478,921 $188.7 p/Share
2,538 Reduced 15.26%
14,094 Common Stock
Dec 21 2021
BUY
Grant, award, or other acquisition
-
5,417 Added 24.57%
16,632 Common Stock
Aug 09 2021
SELL
Open market or private sale
$2,166,800 $200.0 p/Share
10,834 Reduced 49.14%
11,215 Common Stock
Aug 09 2021
BUY
Exercise of conversion of derivative security
$682,542 $63.0 p/Share
10,834 Added 32.95%
22,049 Common Stock
Jun 18 2021
SELL
Open market or private sale
$2,573,900 $175.0 p/Share
14,708 Reduced 56.74%
11,215 Common Stock
Jun 18 2021
BUY
Exercise of conversion of derivative security
$621,008 $52.61 p/Share
11,804 Added 31.29%
25,923 Common Stock
Apr 21 2021
SELL
Open market or private sale
$374,503 $137.08 p/Share
2,732 Reduced 16.21%
14,119 Common Stock
Apr 20 2021
SELL
Payment of exercise price or tax liability
$313,036 $133.15 p/Share
2,351 Reduced 12.24%
16,851 Common Stock
Apr 19 2021
SELL
Open market or private sale
$512,392 $138.26 p/Share
3,706 Reduced 16.18%
19,202 Common Stock
Apr 19 2021
BUY
Grant, award, or other acquisition
-
5,083 Added 18.16%
22,908 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$263,785 $154.26 p/Share
1,710 Reduced 8.75%
17,825 Common Stock
Feb 11 2021
BUY
Grant, award, or other acquisition
-
5,416 Added 21.71%
19,535 Common Stock
Sep 29 2020
SELL
Open market or private sale
$135,940 $140.0 p/Share
971 Reduced 6.43%
14,119 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$40,996 $42.22 p/Share
971 Added 6.05%
15,090 Common Stock

Also insider at

SRRK
Scholar Rock Holding Corp Healthcare
EDIT
Editas Medicine, Inc. Healthcare
AV

Akshay Vaishnaw

President
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Track Activities on ALNY